Security key
G6256B106
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF)
CUSIP: G6256B106
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Class A common stock, par value $0.0001 per share
- Total 13F shares
- 3,015,414
- Total 13F value
- $33,611,838
- Share change
- +813,441
- SEC-reported price per share
- $11.19
- Number of holders
- 17
- Value change
- +$9,084,045
- Number of buys
- 6
- Number of sells
- 1
- Shares outstanding
- 1,261,821
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
17
Top holders
10
DNQAF full security history
Ownership snapshot
Full 13F holder table
Semnur Pharmaceuticals, Inc. SEC filings
Semnur Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GLAZER CAPITAL, LLC
Disclosed value leader
BOOTHBAY FUND MANAGEMENT,...
Comparable rows
10/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 25%
5 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
GLAZER CAPITAL, LLC leads the comparable SEC ownership view at 25%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GLAZER CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
GLAZER CAPITAL, LLC
25%
KIM, LLC
20%
BERKLEY W R CORP
18%
Westchester Capital Management, LLC
18%
Crossingbridge Advisors, LLC
15%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC |
13F
Company
|
25%
|
$3,430,000
310,944 shares
|
— | 31 Mar 2024 |
| KIM, LLC |
13F
Company
|
20%
|
$2,732,135
247,252 shares
|
— | 31 Mar 2024 |
| BERKLEY W R CORP |
13F
Company
|
18%
|
$1,954,298
224,632 shares
|
— | 31 Mar 2024 |
| Westchester Capital Management, LLC |
13F
Company
|
18%
|
$2,485,824
224,555 shares
|
— | 31 Mar 2024 |
| Crossingbridge Advisors, LLC |
13F
Company
|
15%
|
$2,098,252
189,544 shares
|
— | 31 Mar 2024 |
| Centiva Capital, LP |
13F
Company
|
15%
|
$2,080,425
187,764 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
3,015,414
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
17
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|